Advanced Research in Influenza Vaccines and Therapies
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 288
Special Issue Editor
Special Issue Information
Dear Colleagues,
Influenza continues to be a major public health challenge worldwide. Seasonal outbreaks caused by influenza A and B viruses, along with the looming threat of zoonotic strains with pandemic potential, highlight the urgent need for innovative approaches to vaccines and therapies. Moreover, despite annual vaccinations, the rate of viral transmission can still be high, suggesting inadequate or short-lived immune responses following influenza vaccination in humans. Developing effective strategies requires a deeper understanding of the interaction between influenza viruses and the host immune system to harness valuable insights for improving prevention and treatment.
This Special Issue invites contributions that explore advances in influenza vaccine development, including new platforms, adjuvants, and antiviral strategies. We are particularly interested in studies examining the role of the innate immune system, the impact of interferons on host defense, and how viral mechanisms evade these responses. Research into novel adjuvants that enhance immune responses and studies that address vaccine efficacy against evolving strains are also encouraged.
We welcome original research, reviews, and perspectives that delve into these topics and offer insights that could shape the future of influenza prevention and treatment. Let us work together to advance our understanding of influenza and move closer to solutions that can protect us against both seasonal epidemics and potential pandemics.
We look forward to your submissions!
Best regards,
Dr. Sonia Jangra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza vaccines
- innate immunity
- adjuvants
- interferons
- antiviral development
- immune response
- pandemic preparedness
- vaccine innovation
- host–virus interactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
